vancomycin has been researched along with Soft Tissue Infections in 98 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (3.06) | 18.2507 |
| 2000's | 21 (21.43) | 29.6817 |
| 2010's | 60 (61.22) | 24.3611 |
| 2020's | 14 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
| Cavallo, I; Di Domenico, EG; Ensoli, F; Guembe, M; Kovacs, D; Mastrofrancesco, A; Morrone, A; Pasqua, M; Pimpinelli, F; Prignano, G; Sivori, F; Sperduti, I; Toma, L; Truglio, M | 1 |
| Agunsoye, CJ; Akinduti, PA; Akinnola, O; El-Ashker, M; Obafemi, YD; Oladotun, A; Oranusi, SU; Phiri, BSJ; Ugboko, H | 1 |
| Acquisto, NM; Cheon, E; Sacdal, JPA; Stilwell, AM; Treu, CN | 1 |
| Habib, A; Qadir, A | 1 |
| Lv, M; Sun, K; Wang, L; Yang, P; Zhang, S; Zhao, L | 1 |
| Hoyer, EA; Joseph, M; Kaplan, SL; McNeil, JC; Vallejo, JG | 1 |
| Durbin-Johnson, B; Farooqi, AS; Gupta, K; Gupta, MC; Gupta, S; Maitra, S; Pereira, M; Wetpiriyakul, P | 1 |
| Assi, A; Bleibtreu, A; Bouchand, F; Cabaret, P; Camou, F; Chavanet, P; Courjon, J; Davido, B; Denis, E; Dinh, A; Duran, C; Etienne, C; Illes, G; Khatchatourian, L; Lacassin-Beller, F; Lechiche, C; Limonta, S; Lotte, R; Mahieu, R; Monnin, B; Pavese, P; Riou, R; Rouanes, N; Senneville, E | 1 |
| Beard, MC; Cobb, LH; McCabe, EM; Olivier, AK; Park, J; Priddy, LB; Rourke, AS; Seo, KS; Swanson, EA | 1 |
| Cobian, J; Hall, B; Miller, J; Wilson, K | 1 |
| Abreu, MA; Carvalho, R; Couto de Carvalho, A; Reis, E; Santos, T | 1 |
| Bartholomew, TS; Castillo, M; Forrest, DW; Ginoza, MEC; Greven, C; Serota, DP; Tookes, HE | 1 |
| Alosaimy, S; Lagnf, AM; Lodise, TP; Morrisette, T; Murray, KP; Rybak, MJ; Zasowski, EJ | 1 |
| Chen, G; Dong, C; Dong, Y; Fang, Y; Tao, X; Wu, S; Xu, K; Yu, Z; Zhang, L; Zhou, X; Zhu, F | 1 |
| Akalin, H; Ali, R; Bulbul, EN; Kazak, E; Kirkizlar, O; Kirkizlar, TA; Ozakin, C; Ozboz, ES; Ozkalemkas, F; Ozkocaman, V | 1 |
| Davis, TA; Dey, D; Forsberg, JA; Hanson, MA; Moss, KL; Pavey, GJ; Potter, BK; Qureshi, AT; Sanders, EM; Seavey, JG; Tomasino, AM; Wheatley, BM | 1 |
| Candela Fajardo, A; Gallego Muñoz, C; Urbieta Sanz, E | 1 |
| Bavya, MC; George, L; Rohan, KV; Srivastava, R | 1 |
| Benninger, E; Buclin, T; Gautier, E; Guidi, M; Livio, F; Magnin, JL; Rönn, K; Wahl, P | 1 |
| Li, Y; Xu, W | 1 |
| Azzini, AM; Baur, D; Savoldi, A; Tacconelli, E | 1 |
| Aldape, MJ; Bayer, CR; Bryant, AE; Rice, SN; Stevens, DL | 1 |
| Butler-Laporte, G; Cheng, MP; De L'Étoile-Morel, S; Lee, TC; McDonald, EG | 1 |
| Fleck, SC; Frank, J; Janko, M; Marzi, I; Verboket, R | 1 |
| Shekhar, C | 1 |
| Chen, XJ; Gao, W; Hua, CZ; Jing, CM; Lin, AW; Lu, HP; Lyu, Q; Wang, CQ; Xu, HM; Xu, ZW; Yang, LH; Yu, H | 1 |
| Alley, M; Flaherty, M; Lisella, J; Papaliodis, D; Rosenbaum, A | 1 |
| Chen, X; Dong, BR; Liu, GJ; Wu, T; Yang, M; Yue, J | 2 |
| Hanna, N; Yazdani, C | 1 |
| Gould, IM; O'Brien, DJ | 1 |
| Antonopoulou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Tsaganos, T; Tzepi, IM | 1 |
| Hatef, DA; Janis, JE; Reece, EM; Wong, C | 1 |
| Calandra, T; Greub, G; Prod'hom, G; Senn, L; Taffe, P; Tissot, F; Zanetti, G | 1 |
| Dhanireddy, R; Dolapo, O; Talati, AJ | 1 |
| Chambers, R; Charbonneau, C; Eckmann, C; Haider, S; Hajek, P; Lawson, W; Li, JZ; Macahilig, C; Nathwani, D; Simoneau, D; Solem, CT; Stephens, JM | 1 |
| Fan, W; Kongnakorn, T; LaPensee, KT; Pelligra, CG; Revankar, N; Ward, AJ | 1 |
| Bubnova, N; Corey, GR; Good, S; Green, S; Heller, B; Jiang, H; Keech, R; Manos, P; Moeck, G; O'Riordan, W; Singh, R; Wikler, M | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| Steiner, M | 1 |
| Eckmann, C | 1 |
| Fuller, BM; McCammon, C; Mueller, K; Skrupky, L | 1 |
| Nathwani, D; Tsoulas, C | 1 |
| Baillon-Plot, N; Charbonneau, C; Corman, S; Eckmann, C; Haider, S; Lawson, W; Li, J; Macahilig, C; Nathwani, D; Solem, C; Stephens, J | 2 |
| Aiken, SS; Christou, C; Cooper, JJ; Lovric, V; Oliver, RA; Walsh, WR; Yu, Y | 1 |
| Budimir, A | 1 |
| Akamatsu, N; Hasegawa, H; Kawakami, K; Kimura, Y; Kosai, K; Matsuda, J; Matsuo, H; Morinaga, Y; Uno, N; Yamaryo, T; Yanagihara, K | 1 |
| Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F | 1 |
| Changchien, CH; Chen, SW; Chen, YY; Chu, C | 1 |
| Dryden, M; Gonzalez, J; Iaconis, JP; Wilson, D; Zhang, Y | 1 |
| Bowling, FL; Dobson, CB; Lovering, AM; Price, BL | 1 |
| Chen, Y; Dong, DP; Gu, FF; Guo, XK; Han, LZ; Ni, YX; Song, Z | 1 |
| Domínguez-Herrera, J; Labrador-Herrera, G; López-Rojas, R; Pachón, J; Smani, Y | 1 |
| Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
| da Silva, LV; de Souza, MV; Marcadenti, A; Zavascki, AP | 1 |
| Aepinus, C; Podbielski, A; Schmialek, A; Schmitz, S; Zautner, AE | 1 |
| Sakoulas, G | 1 |
| Bounthavong, M; Hsu, DI; Okamoto, MP | 1 |
| Dodds, TJ; Hawke, CI | 1 |
| Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C | 1 |
| Chambers, HF; Deshpande, LM; Diep, BA; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Bounthavong, M; Hsu, DI | 2 |
| Stein, GE; Wells, EM | 1 |
| Baruch, AM; Bhattacharyya, H; Dryden, MS; Itani, KM; Kunkel, MJ; Weigelt, JA | 1 |
| Baculik, T; Corey, GR; Friedland, D; Talbot, GH; Thye, D; Wilcox, MH | 2 |
| Corrado, ML | 1 |
| Dryden, M; Eckmann, C | 1 |
| Amaya-Villar, R; de la Torre, MV; Garnacho-Montero, J; Gómez-Grande, ML; Jerez, V; Lorente-Ramos, L; Loza, A; Martínez, A; Ortiz, C; Pomares, J; Pozo, JC; Sierra, R | 1 |
| Hedge, DD; Hellwig, TR; Laible, BR | 1 |
| Farrell, DJ; Jones, RN; Sader, HS | 1 |
| Chaves, RL; Fierlbeck, G; Loeffler, J; Quist, SR; Seaton, RA | 1 |
| Alverson, JB; Anderson, AC; Frey, KM; Martin, BD; Priestley, ND; Scocchera, EW; Swain Iii, PW; Viswanathan, K; Wright, DL | 1 |
| Baruch, AM; Bhattacharyya, H; Biswas, P; Itani, KM; Reisman, A | 1 |
| Carrascosa, MF; Caviedes, JR; Gutiérrez, PG; Santamaría, MP | 1 |
| Aikawa, N; Kato, Y; Kusachi, S; Mikamo, H; Morita, A; Takesue, Y; Tanaka, Y; Tsumori, K; Watanabe, S; Yoshinari, T | 1 |
| Giuliano, C; Johnson, LB; Kale-Pradhan, PB | 1 |
| Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI | 1 |
| Arbeit, RD; Campanaro, E; Eisenstein, BI; Maki, D; Tally, FP | 1 |
| Chung, YK; Hong, JP; Kim, JJ; Shin, HW; Wei, FC | 1 |
| Polk, HC; Sharpe, JN; Shively, EH | 1 |
| Barriere, SL; Cabell, CH; Chu, VH; Corey, GR; Dunbar, LM; Fowler, VG; Kitt, MM; Lau, WK; O'Riordan, WD; Pien, FD; Spencer, E; Stryjewski, ME; Vallee, M | 1 |
| Dryden, M; Itani, K; Knirsch, C; Lau, W; Stevens, D; Weigelt, J | 1 |
| Wilcox, MH | 1 |
| Charles, PG; Grayson, ML; Howden, BP; Johnson, PD; Ward, PB | 1 |
| Duttagupta, S; Itani, KM; Li, JZ; Weigelt, J | 1 |
| Stevens, DL | 1 |
| Ehrlich, M; Fleck, T; Hutschala, D; Müller, M; Skhirtladze, K; Thalhammer, F; Tschernko, EM; Vukovich, T | 1 |
| Kalil, AC; Puumala, S; Stoner, J | 1 |
| Liu, LZ; McCollum, M; Sorensen, SV | 1 |
| Awad, SS; Berger, DH; Elhabash, SI; Farrow, B; Lee, L | 1 |
| De Cock, E; Duttagupta, S; Resch, A; Schürmann, D; Sorensen, SV | 1 |
| Galloway, KP; Henry, SL | 1 |
| De Pauw, BE; Deresinski, SC; Dompeling, EC; Donnelly, JP; Feld, R; Lane-Allman, EF | 1 |
| Swanston, WH | 1 |
21 review(s) available for vancomycin and Soft Tissue Infections
| Article | Year |
|---|---|
Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children.
Topics: Abscess; Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Child; Humans; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Retrospective Studies; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2023 |
Efficacy and safety of linezolid compared with other treatments for skin and soft tissue infections: a meta-analysis.
Topics: Anti-Bacterial Agents; Humans; Linezolid; Skin; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2018 |
Is there still a role for vancomycin in skin and soft-tissue infections?
Topics: Anti-Bacterial Agents; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Glycopeptides; Humans; Linezolid; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2018 |
MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Biomarkers; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2018 |
Linezolid versus vancomycin for skin and soft tissue infections.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Eruptions; Humans; Length of Stay; Linezolid; Oxazolidinones; Pruritus; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Thrombocytopenia; Vancomycin | 2013 |
Does vancomycin have a future in the treatment of skin infections?
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2014 |
Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2015 |
MRSA in Croatia: prevalence and management.
Topics: Animals; Anti-Bacterial Agents; Carrier State; Cattle; Croatia; Daptomycin; Humans; Linezolid; Livestock; Methicillin-Resistant Staphylococcus aureus; Minocycline; Prevalence; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Swine; Teicoplanin; Tigecycline; Vancomycin; Zoonoses | 2016 |
Linezolid versus vancomycin for skin and soft tissue infections.
Topics: Adult; Anti-Bacterial Agents; Drug Eruptions; Humans; Length of Stay; Linezolid; Pruritus; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Thrombocytopenia; Vancomycin | 2016 |
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin | 2016 |
Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.
Topics: Acetamides; Cost-Benefit Analysis; Decision Support Techniques; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Risk Factors; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis).
Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Randomized Controlled Trials as Topic; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2010 |
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2010 |
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Skin Diseases; Soft Tissue Infections; Tigecycline; Vancomycin | 2010 |
[Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].
Topics: Anti-Bacterial Agents; Critical Care; Critical Illness; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Soft Tissue Infections; Vancomycin; Vancomycin Resistance | 2011 |
Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Health Care Costs; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2012 |
Update on linezolid: the first oxazolidinone antibiotic.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Teicoplanin; Vancomycin | 2005 |
The role of vancomycin in the treatment paradigm.
Topics: Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Failure; Vancomycin | 2006 |
Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bone Cements; Bone Diseases; Cephalosporins; Drug Delivery Systems; Humans; Methylmethacrylates; Microspheres; Osteomyelitis; Penicillins; Soft Tissue Infections; Vancomycin | 1995 |
17 trial(s) available for vancomycin and Soft Tissue Infections
| Article | Year |
|---|---|
Does empiric antibiotic therapy change MRSA [corrected] hand infection outcomes? Cost analysis of a randomized prospective trial in a county hospital.
Topics: Abscess; Adult; Anti-Bacterial Agents; Cefazolin; Community-Acquired Infections; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Hand; Hospital Costs; Hospitals, County; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2014 |
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Male; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin; Young Adult | 2015 |
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Systemic Inflammatory Response Syndrome; Treatment Outcome; Vancomycin; Young Adult | 2016 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
Topics: Acetamides; Americas; Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Bacterial; Europe; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Oxazolidinones; Soft Tissue Infections; South Africa; Staphylococcal Skin Infections; Vancomycin | 2010 |
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chi-Square Distribution; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Topics: Adult; Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
Comparative randomised clinical trial against glycopeptides supports the use of daptomycin as first-line treatment of complicated skin and soft-tissue infections.
Topics: Aged; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2012 |
Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Daptomycin; Female; Humans; Kidney Function Tests; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2013 |
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Daptomycin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillins; Skin Diseases, Infectious; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2004 |
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Administration, Oral; Adult; Aged; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin | 2005 |
Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Male; Middle Aged; Penicillins; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2005 |
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Female; Humans; Internationality; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Americas; Anti-Bacterial Agents; Anti-Infective Agents; Asia; Europe; Female; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin; Methicillin Resistance; Middle Aged; New Zealand; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 1996 |
60 other study(ies) available for vancomycin and Soft Tissue Infections
| Article | Year |
|---|---|
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.
Topics: Anti-Bacterial Agents; Biofilms; DNA; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2022 |
Emerging vancomycin-non susceptible coagulase negative Staphylococci associated with skin and soft tissue infections.
Topics: Coagulase; Drug Resistance, Bacterial; Humans; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus; Vancomycin | 2022 |
Oritavancin versus oral antibiotics for treatment of skin and skin structure infections in the emergency department.
Topics: Anti-Bacterial Agents; Emergency Service, Hospital; Glycopeptides; Humans; Lipoglycopeptides; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2022 |
Frequency and Antibiotic Susceptibility Pattern of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) in Uncomplicated Skin and Soft Tissue Infections.
Topics: Agar; Amikacin; Animals; Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Female; Furunculosis; Humans; Impetigo; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin | 2022 |
Population Pharmacokinetics and Dosage Optimization of Vancomycin in Pediatric Patients with Skin and Soft Tissue Infections, Bone, and Joint Infections.
Topics: Anti-Bacterial Agents; Child; Humans; Models, Biological; Soft Tissue Infections; Vancomycin | 2023 |
Impact of implant metal type and vancomycin prophylaxis on postoperative spine infection: an in-vivo study.
Topics: Animals; Anti-Bacterial Agents; Cobalt; Methicillin-Resistant Staphylococcus aureus; Powders; Prosthesis-Related Infections; Rabbits; Soft Tissue Infections; Spinal Diseases; Stainless Steel; Titanium; Vancomycin | 2023 |
French national cohort of first use of dalbavancin: A high proportion of off-label use.
Topics: Adult; Anti-Bacterial Agents; Endocarditis; Female; France; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Off-Label Use; Retrospective Studies; Soft Tissue Infections; Staphylococcal Infections; Surveys and Questionnaires; Teicoplanin; Treatment Outcome; Vancomycin | 2019 |
CRISPR-Cas9 modified bacteriophage for treatment of Staphylococcus aureus induced osteomyelitis and soft tissue infection.
Topics: Animals; Anti-Bacterial Agents; Bacteriophages; Biofilms; CRISPR-Cas Systems; Disease Models, Animal; Female; Fosfomycin; Gene Editing; Longitudinal Studies; Osteomyelitis; Rats; Rats, Sprague-Dawley; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2019 |
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin | 2020 |
Evidence Associated with the Use of Oxazolidinones in the Treatment of Skin and Skin Structure Infections: A Retrospective Study.
Topics: Humans; Oxazolidinones; Retrospective Studies; Soft Tissue Infections; Vancomycin | 2020 |
When is an abscess more than an abscess? Syringe services programs and the harm reduction safety-net: a case report.
Topics: Abscess; Anti-Bacterial Agents; Buprenorphine; Doxycycline; Harm Reduction; HIV Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Needle-Exchange Programs; Opioid-Related Disorders; Soft Tissue Infections; Staphylococcal Infections; Substance Abuse, Intravenous; Vancomycin | 2020 |
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Vogesella perlucida-induced bacteremia in an advanced-age patient: first case report.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Betaproteobacteria; Female; Humans; Levofloxacin; RNA, Ribosomal, 16S; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2020 |
Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Daptomycin; Enterococcus faecium; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sex Factors; Soft Tissue Infections; Turkey; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2020 |
Early local delivery of vancomycin suppresses ectopic bone formation in a rat model of trauma-induced heterotopic ossification.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cell Proliferation; Cytokines; Drug Evaluation, Preclinical; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Ossification, Heterotopic; Rats, Sprague-Dawley; Soft Tissue Infections; Staphylococcal Infections; Systemic Inflammatory Response Syndrome; Vancomycin; Wounds and Injuries; X-Ray Microtomography | 2017 |
[Dalbavancin in the treatment of skin and soft tissues infection].
Topics: Anti-Bacterial Agents; Drug Eruptions; Female; Humans; Middle Aged; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Vancomycin | 2017 |
A therapeutic polyelectrolyte-vitamin C nanoparticulate system in polyvinyl alcohol-alginate hydrogel: An approach to treat skin and soft tissue infections caused by Staphylococcus aureus.
Topics: Alginates; Animals; Anti-Bacterial Agents; Ascorbic Acid; Cell Line; Drug Compounding; Drug Liberation; Fibroblasts; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Mice; Nanoparticles; Permeability; Polyesters; Polyvinyl Alcohol; Skin; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Swine; Tissue Culture Techniques; Vancomycin | 2017 |
The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Calcium Sulfate; Drug Carriers; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Orthopedic Procedures; Osteomyelitis; Prospective Studies; Prosthesis-Related Infections; Soft Tissue Infections; Vancomycin | 2017 |
Comparative efficacy of antibiotics in treating experimental Clostridium septicum infection.
Topics: Animals; Anti-Bacterial Agents; Clindamycin; Clostridium Infections; Clostridium septicum; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Injections, Intraperitoneal; Mice; Microbial Sensitivity Tests; Muscle, Skeletal; Penicillins; Soft Tissue Infections; Survival Analysis; Tetracycline; Vancomycin | 2018 |
Local fixation of antibiotics with fibrin spray on soft tissues: experimental study on the relevance of the application techniques.
Topics: Animals; Anti-Bacterial Agents; Debridement; Fibrin Tissue Adhesive; Male; Rats; Rats, Sprague-Dawley; Soft Tissue Infections; Vancomycin | 2020 |
An Innovative Technique in Local Antibiotic Delivery Method in Open Infected Wounds of the Musculoskeletal System.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Cholecalciferol; Cohort Studies; Drug Carriers; Female; Fractures, Open; Humans; Male; Middle Aged; Osteomyelitis; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Soft Tissue Infections; Staphylococcal Infections; Tobramycin; Vancomycin; Wound Healing; Wound Infection | 2019 |
A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.
Topics: Ceftriaxone; Child, Preschool; China; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Fever; Humans; Infant; Infant, Newborn; Male; Penicillins; Pneumonia, Pneumococcal; Retrospective Studies; Sepsis; Shock, Septic; Skin Diseases, Bacterial; Soft Tissue Infections; Streptococcal Infections; Streptococcus pyogenes; Tertiary Care Centers; Vancomycin | 2019 |
Bacillus cereus fasciitis: a unique pathogen and clinically challenging sequela of inoculation.
Topics: Anti-Bacterial Agents; Bacillus cereus; Child; Clindamycin; Debridement; Fasciitis; Fasciotomy; Gram-Positive Bacterial Infections; Humans; Lower Extremity; Male; Meropenem; Reoperation; Soft Tissue Infections; Therapeutic Irrigation; Thienamycins; Vancomycin; Wounds, Penetrating | 2013 |
Comparative analysis of empiric antimicrobial treatments for skin and soft tissue infections in newly hospitalized patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Electronic Health Records; Female; Hospitalization; Humans; Length of Stay; Likelihood Functions; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2014 |
Comparative efficacy of tigecycline VERSUS vancomycin in an experimental model of soft tissue infection by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Drug Administration Schedule; Exotoxins; Immunocompromised Host; Injections, Intraperitoneal; Kaplan-Meier Estimate; Leukocidins; Lipid Peroxidation; Male; Methicillin-Resistant Staphylococcus aureus; Minocycline; Random Allocation; Rats, Wistar; Soft Tissue Infections; Staphylococcal Infections; Thigh; Tigecycline; Vancomycin; Virulence | 2015 |
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood; Cross Infection; Echocardiography; Female; Hospital Mortality; Humans; Infectious Disease Medicine; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organizational Policy; Practice Guidelines as Topic; Referral and Consultation; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2014 |
Trends of Staphylococcus aureus bloodstream infections in a neonatal intensive care unit from 2000-2009.
Topics: Anti-Bacterial Agents; Birth Weight; Clindamycin; Enterocolitis, Necrotizing; Hospital Mortality; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Retrospective Studies; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Tennessee; Vancomycin | 2014 |
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Europe; Female; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Patient Discharge; Practice Guidelines as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2014 |
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections.
Topics: Acetamides; Acute Disease; Administration, Intravenous; Anti-Bacterial Agents; Daptomycin; Health Expenditures; Humans; Linezolid; Oxazolidinones; Patient Discharge; Skin Diseases, Bacterial; Soft Tissue Infections; United States; Vancomycin | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Cochrane in context: Linezolid versus vancomycin for skin and soft tissue infections.
Topics: Acetamides; Anti-Bacterial Agents; Humans; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2014 |
[Efficacy of ceftaroline in treating complicated skin and soft tissue infections].
Topics: Aztreonam; Ceftaroline; Cephalosporins; Drug Therapy, Combination; Humans; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin | 2014 |
Vancomycin Use in Patients Discharged From the Emergency Department: A Retrospective Observational Cohort Study.
Topics: Abscess; Administration, Intravenous; Adult; Anti-Bacterial Agents; Emergency Service, Hospital; Female; Humans; Inappropriate Prescribing; Male; Medical Audit; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Discharge; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2015 |
Comparison of vancomycin and linezolid in patients with peripheral vascular disease and/or diabetes in an observational European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Diabetes Complications; Europe; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2015 |
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Daptomycin; Diabetes Complications; Europe; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin; Young Adult | 2015 |
Development of a Novel Model for the Assessment of Dead-Space Management in Soft Tissue.
Topics: Absorbable Implants; Animals; Debridement; Humans; Interleukin-6; Models, Animal; Rabbits; Soft Tissue Infections; Tumor Necrosis Factor-alpha; Vancomycin; Wound Healing; X-Ray Microtomography | 2015 |
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cross Infection; Daptomycin; Dibekacin; Exotoxins; Humans; Japan; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Open Reading Frames; Recombinases; Secondary Care Centers; Skin; Soft Tissue Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Toxins; Catheter-Related Infections; Clindamycin; Community-Acquired Infections; Cross Infection; Erythromycin; Exfoliatins; Exotoxins; Female; Genotype; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Superantigens; Taiwan; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection.
Topics: Anti-Bacterial Agents; Biofilms; Calcium Sulfate; Collagen; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Staphylococcal Infections; Tobramycin; Vancomycin; Wound Infection | 2016 |
Molecular Epidemiology of Staphylococcus aureus among Patients with Skin and Soft Tissue Infections in Two Chinese Hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; China; Female; Hospitals; Humans; Infant; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2016 |
Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Ceftaroline; Cephalosporins; Disease Models, Animal; Female; Foreign Bodies; Methicillin Resistance; Mice, Inbred C57BL; Microbial Sensitivity Tests; Random Allocation; Sepsis; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2016 |
Caution when reconsidering empiric antimicrobial therapy for methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Incidence; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2008 |
Subcutaneous fistulae in a patient with femoral hypoplasia due to Actinomyces europaeus and Actinomyces turicensis.
Topics: Actinomyces; Actinomycosis; Antifungal Agents; Cefuroxime; Femur; Fistula; Humans; Immunocompetence; Knee Joint; Lower Extremity Deformities, Congenital; Male; RNA, Bacterial; RNA, Ribosomal, 16S; Soft Tissue Infections; Surgical Wound Infection; Vancomycin; Young Adult | 2009 |
Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy.
Topics: Anti-Bacterial Agents; Daptomycin; Humans; Leukemia, Myeloid, Acute; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutropenia; Soft Tissue Infections; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2008 |
Susceptibility of Staphylococcus aureus to vancomycin: analysis of minimum inhibitory concentrations in two tertiary care hospitals in eastern South Dakota.
Topics: Anti-Bacterial Agents; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Soft Tissue Infections; South Dakota; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2011 |
Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009).
Topics: Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Soft Tissue Infections; Vancomycin | 2011 |
Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes.
Topics: Alkynes; Anti-Bacterial Agents; Drug Resistance, Bacterial; Folic Acid Antagonists; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Skin Diseases; Soft Tissue Infections; Species Specificity; Streptococcus pyogenes; Vancomycin | 2012 |
Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clinical Trials, Phase IV as Topic; Female; Humans; Infusions, Intravenous; Linezolid; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Oxazolidinones; Propensity Score; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2012 |
Necrotising soft-tissue infection.
Topics: Anti-Bacterial Agents; Arm; Clindamycin; Debridement; Female; Forearm; Humans; Hyperbaric Oxygenation; Middle Aged; Necrosis; Radiography; Soft Tissue Infections; Vancomycin | 2012 |
Early response of ceftaroline fosamic in the treatment of soft-tissue infections.
Topics: Anti-Bacterial Agents; Aztreonam; Ceftaroline; Cephalosporins; Community-Acquired Infections; Endpoint Determination; Humans; Pneumonia; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Time Factors; Treatment Outcome; Vancomycin | 2012 |
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice.
Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing | 2013 |
The use of anterolateral thigh perforator flaps in chronic osteomyelitis of the lower extremity.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chronic Disease; Combined Modality Therapy; Debridement; Diabetic Foot; Female; Fibula; Fractures, Open; Humans; Leg; Leg Injuries; Male; Methicillin Resistance; Middle Aged; Osteomyelitis; Plastic Surgery Procedures; Recovery of Function; Soft Tissue Infections; Staphylococcal Infections; Surgical Flaps; Surgical Wound Dehiscence; Tibial Fractures; Vancomycin; Wound Healing | 2005 |
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility?
Topics: Acetamides; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery.
Topics: Aged; Cardiac Surgical Procedures; Diabetes Mellitus; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Postoperative Complications; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2006 |
Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus?
Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in
Topics: Acetamides; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Health Care Costs; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; United States; Vancomycin | 2007 |
Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Incidence; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Vancomycin | 2007 |
Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Decision Support Techniques; Delphi Technique; Germany; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2009 |
Methicillin resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cause of Death; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Hand Disinfection; Hospitals, General; Humans; Intensive Care Units; Methicillin Resistance; Patient Isolation; Prevalence; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Surgery Department, Hospital; Surgical Wound Infection; Trinidad and Tobago; Vancomycin | 1999 |